Minimal Residual Disease (MRD) refers to the small number of cancer cells that may remain in a patient's body after treatment and are below the detection threshold of traditional diagnostic methods. Detecting and monitoring MRD is crucial for assessing the risk of relapse and tailoring personalized treatment strategies in hematological malignancies and some solid tumors.